This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignee: Shionogi Company Limited. Active years: 2012-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2015
Title: Takayuki Okuno: Innovator in Pharmaceutical Chemistry
Introduction
Takayuki Okuno is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with therapeutic potential. With a total of 4 patents to his name, Okuno's work is recognized for its innovative approach to drug design.
Latest Patents
One of Okuno's latest patents is focused on an amine derivative that exhibits NPY Y5 receptor antagonistic activity. This invention provides a compound of the formula (I), which includes a pharmaceutically acceptable salt or solvate. The compound features various substituents, including lower alkyl groups and specific functional groups that enhance its pharmacological properties. Another patent also centers on an amine derivative with similar receptor antagonistic activity, showcasing the versatility and potential of his chemical innovations.
Career Highlights
Okuno is currently associated with Shionogi Company Limited, a leading pharmaceutical company known for its commitment to research and development. His work at Shionogi has allowed him to explore new avenues in drug discovery and development, contributing to the advancement of medical science.
Collaborations
Throughout his career, Okuno has collaborated with notable colleagues, including Masahiro Sakagami and Naoki Kouyama. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in the pharmaceutical field.
Conclusion
Takayuki Okuno's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to pave the way for new therapeutic options, demonstrating the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
